Search
News & Events
Listen Up - Urgent action needed to reduce ear infectionsListen Up - Urgent action needed to reduce ear infections
News & Events
Be on alert for meningitisThe Meningitis Centre is urging all people to be on alert for the signs and symptoms of the potential deadly disease.
News & Events
New vaccine could protect against more types of cancer-causing HPVTrial of new vaccine that could provide women with additional protection against Human Papillomavirus (HPV) types known to cause cervical cancer.
News & Events
Potential new vaccine for WA's meningococcal threatPerth researchers are about to trial a new vaccine that could potentially provide protection against the most common form of meningococcal
Research
Determinants of attenuation in the envelope protein of the flavivirus AlfuyMurray Valley encephalitis virus (MVEV) is a mosquito-borne flavivirus endemic to Australia and Papua New Guinea.
As Head of Aboriginal Research Development at Telethon Kids, Glenn Pearson believes his work brings us closer to identifying the real and whole Australian story
Research
Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programmeThese data support that children are not just 'little adults' in the AMR era, and analyses by age group are important to detect differences in antibiotic susceptibility
Research
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statementThe Australian Technical Advisory Group on Immunisation and New Zealand Ministry of Health recommend all children aged ≥ 5 years receive either of the two mRNA COVID-19 vaccines: Comirnaty (Pfizer), available in both Australia and New Zealand, or Spikevax (Moderna), available in Australia only. Both vaccines are efficacious and safe in the general population, including children. Children and adolescents undergoing treatment for cancer and immunosuppressive therapy for non-malignant haematological conditions are particularly vulnerable, with an increased risk of severe or fatal COVID-19.
Research
Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of LifeDevelopment of vaccines to prevent disease and death from Streptococcus pneumoniae, and nontypeable Haemophilus influenzae (NTHi), the main pathogens that cause otitis media, pneumonia, meningitis and sepsis, are a global priority.